Rosiglitazone protects dopaminergic neurons against lipopolysaccharide- induced neurotoxicity through inhibition of microglia activation

International Journal of Neuroscience

Volumn 122, Issue 9, 2012, Pages 532-540

  He, Xiuquan ^a   Feng, Lei ^a   Meng, Haiwei ^a   Wang, Xiaohong ^a   Liu, Shuwei ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

dopaminergic neurons; microglia; Parkinson's disease; rosiglitazone

Indexed keywords

LIPOPOLYSACCHARIDE; NITRIC OXIDE; ROSIGLITAZONE; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FEMALE; INTRACELLULAR SIGNALING; MICROGLIA; NEUROTOXICITY; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD; CELL COUNT; CELLS, CULTURED; COCULTURE TECHNIQUES; DOPAMINERGIC NEURONS; EMBRYO, MAMMALIAN; FEMALE; GENE EXPRESSION REGULATION; HYPOGLYCEMIC AGENTS; LIPOPOLYSACCHARIDES; MESENCEPHALON; MICROGLIA; NF-KAPPA B; NITRIC OXIDE; PREGNANCY; PROTEIN TRANSPORT; RATS; SUPEROXIDE DISMUTASE; THIAZOLIDINEDIONES; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE 3-MONOOXYGENASE;

EID: 84864917960     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2012.686544     Document Type: Article

References (60)

1. Tansey MG, Goldberg MS. Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis. 2010;37:510-18.
2. Liu B, Wang K, Gao HM, Mandavilli B, Wang JY, Hong JS. Molecular consequences of activated microglia in the brain: Overactivation induces apoptosis. J Neurochem. 2001;77:182-9. (Pubitemid 32245092)
3. Liu B, Hong JS. Role of microglia in inflammation-mediated neurodegenerative diseases: Mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther. 2003;304:1-7. (Pubitemid 36008905)
4. Block ML, Hong JS. Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism. Prog Neurobiol. 2005;76:77-98. (Pubitemid 41242883)
5. Dheen ST, Kaur C, Ling EA. Microglia activation and its implications in the brain diseases. Curr Med Chem. 2007;14:1189-97. (Pubitemid 46739320)
6. McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology. 1988;38:1285-91.
7. Liu B, Du L, Hong JS. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. J Pharmacol Exp Ther. 2000;293:607-17. (Pubitemid 30244114)
8. Arimoto T, Bing G. Up-regulation of inducible nitric oxide synthase in the substantia nigra by lipopolysaccharide causes microglia activation and neurodegeneration. Neurobiol Dis. 2003;12:35-45. (Pubitemid 36259966)
9. Arimoto T, Choi DY, Lu X, Liu M, Nguyen XV, Zheng N, Stewart CA, Kim HC, Bing G. Interleukin-10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantia nigra. Neurobiol Aging. 2007;28:894-906. (Pubitemid 46589742)
10. Liu Y, Qin L, Li G, Zhang W, An L, Liu B, Hong JS. Dextromethorphan protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglia activation. J Pharmacol Exp Ther. 2003;305:212-8. (Pubitemid 36373853)
11. Choi SH, Lee DY, Chung ES, Hong YB, Kim SU, Jin BK. Inhibition of thrombin-induced microglia activation and NADPH oxidase by minocycline protects dopaminergic neurons in the substantia nigra in vivo. J Neurochem. 2005;95:1755-65. (Pubitemid 41804071)
12. Hunter RL, Dragicevic N, Seifert K, Choi DY, Liu M, Kim HC, Cass WA, Sullivan PG, Bing G. Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system. J Neurochem. 2007;100:1375-86.
13. Zhu Y, Alvares K, Huang, Q, Rao MS, Reddy JK. Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver. J Biol Chem. 1993;268: 26817-20. (Pubitemid 24006385)
14. Zhu Y, Qi C, Jain S, Rao MS, Reddy JK. Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor. J Biol Chem. 1997;272: 25500-6. (Pubitemid 27438856)
15. Daynes RA, Jones DC. Emerging roles of PPARs in inflammation and immunity. Nat Rev Immunol. 2002;2:748-59. (Pubitemid 37328715)
16. Kielian T, Drew PD. Effects of peroxisome proliferatoractivated receptor-gamma agonists on central nervous system inflammation. J Neurosci Res. 2003;71:315-25. (Pubitemid 36159491)
17. Bernardo A, Ajmone-Cat MA, Gasparini L, Ongini E, Minghetti L. Nuclear receptor peroxisome proliferatoractivated receptor-gamma is activated in rat microglial cells by the anti-inflammatory drug HCT1026, a derivative of flurbiprofen. J Neurochem. 2005;92:895-903. (Pubitemid 40229562)
18. Randy LH, Bing G. Agonism of peroxisome proliferator Receptor-gamma may have therapeutic potential for neuroinflammation and Parkinson's disease. Curr Neuropharmacol. 2007;5:35-46. (Pubitemid 46488265)
19. Ricote M, Li AC, Willson T M, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature. 1998;391:79-82. (Pubitemid 28079218)
20. Jiang C, Ting AT, Seed B. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature. 1998;391:82-6. (Pubitemid 28079219)
21. Luna-Medina R, Cortes-CanteliM, AlonsoM, Santos A, Martnez A, Perez-Castillo A. Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor gamma activation. J Biol Chem. 2005;280:21453-62. (Pubitemid 40805710)
22. Park SW, Yi JH, Miranpuri G, Satriotomo I, Bowen K, Resnick DK, Vemuganti R. Thiazolidinedione class of peroxisome proliferatoractivated receptor gamma agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats. J Pharmacol Exp Ther. 2007;320:1002-12. (Pubitemid 46294061)
23. Breidert T, Callebert J, Heneka MT, Landreth G, Launay JM, Hirsch EC. Protective action of the peroxisome proliferatoractivated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease. J Neurochem. 2002;82:615-24. (Pubitemid 34831499)
24. Dehmer T, HenekaMT, Sastre M, Dichgans J, Schulz JB. Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation. J Neurochem. 2004;88:494-501. (Pubitemid 38084565)
25. Hunot S, Brugg B, Ricard D, Michel PP, Muriel MP, Ruberg M, Faucheux BA, Agid Y, Hirsch EC. Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease. Proc Natl Acad Sci. 1997;94:7531-6. (Pubitemid 27345350)
26. Xing B, Liu M, Bing G. Neuroprotection with pioglitazone against LPS insult on dopaminergic neurons may be associated with its inhibition of NF-kappaB and JNK activation and suppression of COX-2 activity. J Neuroimmunol. 2007;192:89-98. (Pubitemid 350213119)
27. Koistinaho M, Koistinaho J. Role of p38 and p44/42 mitogenactivated protein kinases in microglia. Glia. 2002;40:175-83. (Pubitemid 35337375)
28. Xie Z, Smith CJ, Van Eldik LJ. Activated glia induce neuron death via MAP kinase signaling pathways involving JNK and p38. Glia. 2004;45:170-9. (Pubitemid 38196993)
29. Zhou Y, Ling EA, Dheen ST. Dexamethasone suppresses monocyte chemoattractant protein-1 production via mitogen activated protein kinase phosphatase-1 dependent inhibition of Jun N-terminal kinase and p38 mitogen-activated protein kinase in activated rat microglia. J Neurochem. 2007;102:667-78. (Pubitemid 47057277)
30. Lee DY, Oh YJ, Jin BK. Thrombin-activated microglia contribute to death of dopaminergic neurons in rat mesencephalic cultures: Dual roles of mitogen-activated protein kinase signaling pathways. Glia. 2005;51:98-110. (Pubitemid 41277344)
31. Xing B, Xin T, Hunter RL, Bing G. Pioglitazone inhibition of lipopolysaccharide-induced nitric oxide synthase is associated with altered activity of p38 MAP kinase and PI3K/Akt. J Neuroinflamm. 2008;5:4.
32. Schintu N, Frau L, Ibba M, Caboni P, Garau A, Carboni E, Carta AR. PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease. Eur J Neurosci. 2009;29:954-63.
33. Carta AR, Frau L, Pisanu A, Wardas J, Spiga S, Carboni E. Rosiglitazone decreases peroxisome proliferator receptorgamma levels in microglia and inhibits TNF-alpha production: New evidences on neuroprotection in a progressive Parkinson's disease model. Neuroscience. 2011;194:250-61.
34. Jongeneel CV. Transcriptional regulation of the tumor necrosis factor alpha gene. Immunobiology. 1995;193:210-6.
35. Banati RB, Gehrmann J, Schubert P, Kreutzberg GW. Cytotoxicity of microglia. Glia. 1993;7:111-8.
36. Arai H, Furuya T, Yasuda T, Miura M, Mizuno Y, Mochizuki H. Neurotoxic effects of lipopolysaccharide on nigral dopaminergic neurons are mediated by microglia activation, interleukin-1beta, and expression of caspase-11 in mice. J Biol Chem. 2004;279:51647-53. (Pubitemid 40017915)
37. Ryu J, Pyo H, Jou I, Joe E. Thrombin induces NO release from cultured rat microglia via protein kinase C, mitogenactivated protein kinase, and NF-kappa B. J Biol Chem. 2000;275:29955-9.
38. Katsuki H, Okawara M, Shibata H, Kume T, Akaike A. Nitric oxide-producing microglia mediate thrombin-induced degeneration of dopaminergic neurons in rat midbrain slice culture. J Neuroche. 2006;97:1232-42. (Pubitemid 43725564)
39. Kim YS, Joh TH. Microglia, major player in the brain inflammation: Their roles in the pathogenesis of Parkinson's disease. Exp Mol Med. 2006;38:333-47.
40. Tikka TM, Koistinaho JE. Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. J Immunol. 2001;166:7527-33. (Pubitemid 32525632)
41. Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C, Choi DK, Ischiropoulos H, Przedborski S. Blockade of microglia activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci. 2002;22:1763-71.
42. BlockML, Li G, Qin L,Wu X, Pei Z,Wang T, Wilson B, Yang J, Hong JS. Potent regulation of microglia-derived oxidative stress and dopaminergic neuron survival: substance P vs. dynorphin. FASEB J. 2006;20:251-8. (Pubitemid 44933172)
43. Woster AP, Combs CK. Differential ability of a thiazolidinedione PPARgamma agonist to attenuate cytokine secretion in primary microglia and macrophage-like cells. J Neurochem. 2007;103:67-76. (Pubitemid 47404200)
44. Jung TW, Lee JY, Shim WS, Kang ES, Kim SK, Ahn CW, Lee HC, Cha BS. Rosiglitazone protects human neuroblastoma SHSY5Y cells against MPP+ induced cytotoxicity via inhibition of mitochondrial dysfunction and ROS production. J Neurol Sci. 2007;253:53-60. (Pubitemid 46185454)
45. Chiang MC, Chern Y, Huang RN. PPARgamma rescue of the mitochondrial dysfunction in Huntington's disease. Neurobiol Dis. 2012;45:322-8.
46. McGuire SO, Ling ZD, Lipton JW, Sortwell CE, Collier TJ, Carvey PM. Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons. Exp Neurol. 2001;169:219-30. (Pubitemid 32524418)
47. Le W, Rowe D, Xie W, Ortiz I, He Y, Appel SH. Microglia activation and dopaminergic cell injury: An in vitro model relevant to Parkinson's disease. J Neurosci. 2001;21:8447-55. (Pubitemid 33051443)
48. Chen CC,Wang JK. p38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages. Mol Pharmacol. 1999;55:481-8.
49. Jung HW, Son HY, Minh CV, Kim YH, Park YK. Methanol extract of Ficus leaf inhibits the production of nitric oxide and proinflammatory cytokines in LPS-stimulated microglia via the MAPK pathway. Phytother Res. 2008;22:1064-9.
50. Nam KN, Son MS, Park JH, Lee EH. Shikonins attenuate microglial inflammatory responses by inhibition of ERK, Akt, and NF-kappaB: Neuroprotective implications. Neuropharmacology. 2008;55:819-25.
51. Watters JJ, Sommer JA, Pfeiffer ZA, Prabhu U, Guerra AN,Bertics PJ. A differential role for the mitogen-activated protein kinases in lipopolysaccharide signaling: TheMEK/ERK pathway is not essential for nitric oxide and interleukin-1beta production. J Biol Ch m. 2002;277:9077-87 (Pubitemid 34952983)
52. Flohé L, Brigelius-Flohé R, Saliou C, Traber MG, Packer L. Redox regulation of NF-kappa B activation. Free Radic Biol Med. 1997;22:1115-26. (Pubitemid 27084148)
53. Konishi H, Tanaka M, Takemura Y, Matsuzaki H, Ono Y, Kikkawa U, Nishizuka Y. Activation of protein kinase C by tyrosine phosphorylation in response to H2O2. Proc Natl Acad Sci USA. 1997;9421:11233-7. (Pubitemid 27450981)
54. Ajizian SJ, English BK, Meals EA. Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-gamma. J Infect Dis. 1999;179:939-44. (Pubitemid 29159340)
55. Klegeris A, McGeer PL. Interaction of various intracellular signaling mechanisms involved in mononuclear phagocyte toxicity toward neuronal cells. J Leukoc Biol. 2000;67: 127-33. (Pubitemid 30046827)
56. Qian L, Wei SJ, Zhang D, Hu X, Xu Z, Wilson B, El-Benna J, Hong JS, Flood PM. Potent anti-inflammatory and neuroprotective effects of TGF-beta1 aremediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in microglia. J Immuno. 2008;181:660-8.
57. Egger T, Hammer A, Wintersperger A, Goti D, Malle E, Sattler W. Modulation of microglial superoxide production by alpha-tocopherol in vitro: Attenuation of p67(phox) translocation by a protein phosphatase-dependent pathway. J Neurochem. 2001;79:1169-82. (Pubitemid 34019795)
58. 2+ disturbance in microglia activation-mediated dopaminergic cell degeneration. Mech Ageing Dev. 2005;126:1241-54. (Pubitemid 41572241)
59. Pyo H, Jou I, Jung S, Hong S, Joe EH. Mitogen-activated protein kinases activated by lipopolysaccharide and beta-amyloid in cultured rat microglia. Neuroreport. 1998;9:871-4. (Pubitemid 28179292)
60. Qin L, Liu Y, Wang T, Wei SJ, Block ML, Wilson B, Liu B, Hong JS. NADPH oxidase mediates lipopolysaccharideinduced neurotoxicity and proinflammatory gene expression in activated microglia. J Biol Chem. 2004;279:1415-21. (Pubitemid 38082669)